Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate if an orally disintegrating tablet of sildenafil will have similar
pharmacokinetic properties as the conventional tablet of sildenafil.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.